These studies collectively indicate that the central biological processes targeted by U2AF1 mutations in myeloid malignancies include RNA splicing and processing, ribosome biogenesis, mitochondrial dysfunction, DNA damage, cell cycle, autophagy, and pyroptosis. The gene discussed is U2AF1; the disease is myeloid neoplasm.